As our results suggested that GPR68 activation enhances acidosis-induced endothelial barrier disruption and inflammation, we next tested the hypothesis that GPR68 inhibition rescues acidic pH-derived endothelial dysfunction. The gene discussed is GPR68; the disease is endothelial dysfunction.